Christine Shaw

Dr. Shaw has served as the Vice President, of Assay Development since July 2020, and has held various roles of increasing responsibility within research and development since joining the company in June 2015. Dr. Shaw has over 16 years of research and diagnostic product development experience and previously held roles with Baylor College of Medicine Medical Genetics Laboratories, Roche-NimbleGen, and Third Wave Technologies. Dr. Shaw received her B.S in Genetics from the University of Wisconsin-Madison and her Ph.D. in Molecular and Human Genetics from Baylor College of Medicine.